Potent antibacterial activity against Gram-negative community and hospital-acquired infections highlighted across eight posters and two presentationSEDMONTON, Alberta , April 19, 2026 (GLOBE NEWSWIRE) ...
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two. The solution is ...
Prospective randomized, open-label, multiple dose Phase 1 clinical trial This study was designed to evaluate the early and extended early bactericidal activity (EBA) of fluoroquinolone antibiotics ...
Cutting-edge tuberculosis therapy: Researchers test quabodepistat combinations, aiming for shorter, safer treatments to combat drug resistance and improve patient outcomes. Study: Safety, ...
Background: Ultraviolet (UV) light is used for phototherapy in dermatology, and UVB light (around 310 nm) is effective for treatment of psoriasis and atopic dermatitis. In addition, it is known that ...
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two. The solution is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results